The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Implantable Drug-Eluting Devices-Global Market Insights and Sales Trends 2024

Implantable Drug-Eluting Devices-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1864820

No of Pages : 106

Ask Your Query
Synopsis
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global Implantable Drug-Eluting Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Implantable Drug-Eluting Devices in various end use industries. The expanding demands from the Diabetes, Contraception, HIV/AIDS Prevention and Chronic Pain Management, are propelling Implantable Drug-Eluting Devices market. Implantable Drug Infusion Pumps, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intraocular Drug-Eluting Devices segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Implantable Drug-Eluting Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Implantable Drug-Eluting Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Implantable Drug-Eluting Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Implantable Drug-Eluting Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Implantable Drug-Eluting Devices covered in this report include Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation and Titan Pharmaceuticals, Inc., etc.
The global Implantable Drug-Eluting Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical
Global Implantable Drug-Eluting Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Implantable Drug-Eluting Devices market, Segment by Type:
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Global Implantable Drug-Eluting Devices market, by Application
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Implantable Drug-Eluting Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Implantable Drug-Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Implantable Drug-Eluting Devices Market Overview
1.1 Implantable Drug-Eluting Devices Product Overview
1.2 Implantable Drug-Eluting Devices Market Segment by Type
1.2.1 Implantable Drug Infusion Pumps
1.2.2 Intraocular Drug-Eluting Devices
1.2.3 Contraceptive Drug-Eluting Devices
1.2.4 Drug-Eluting Stents
1.2.5 Others
1.3 Global Implantable Drug-Eluting Devices Market Size by Type
1.3.1 Global Implantable Drug-Eluting Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Implantable Drug-Eluting Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Implantable Drug-Eluting Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Implantable Drug-Eluting Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Implantable Drug-Eluting Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Implantable Drug-Eluting Devices Sales Breakdown by Type (2018-2023)
2 Global Implantable Drug-Eluting Devices Market Competition by Company
2.1 Global Top Players by Implantable Drug-Eluting Devices Sales (2018-2023)
2.2 Global Top Players by Implantable Drug-Eluting Devices Revenue (2018-2023)
2.3 Global Top Players by Implantable Drug-Eluting Devices Price (2018-2023)
2.4 Global Top Manufacturers Implantable Drug-Eluting Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Implantable Drug-Eluting Devices Market Competitive Situation and Trends
2.5.1 Implantable Drug-Eluting Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Implantable Drug-Eluting Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Drug-Eluting Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Implantable Drug-Eluting Devices Market
2.8 Key Manufacturers Implantable Drug-Eluting Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Implantable Drug-Eluting Devices Status and Outlook by Region
3.1 Global Implantable Drug-Eluting Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Implantable Drug-Eluting Devices Historic Market Size by Region
3.2.1 Global Implantable Drug-Eluting Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Implantable Drug-Eluting Devices Sales in Value by Region (2018-2023)
3.2.3 Global Implantable Drug-Eluting Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Implantable Drug-Eluting Devices Forecasted Market Size by Region
3.3.1 Global Implantable Drug-Eluting Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Implantable Drug-Eluting Devices Sales in Value by Region (2024-2029)
3.3.3 Global Implantable Drug-Eluting Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Implantable Drug-Eluting Devices by Application
4.1 Implantable Drug-Eluting Devices Market Segment by Application
4.1.1 Diabetes
4.1.2 Contraception
4.1.3 HIV/AIDS Prevention
4.1.4 Chronic Pain Management
4.1.5 Cardiovascular
4.1.6 Ophthalmology
4.1.7 Oncology
4.1.8 Others
4.2 Global Implantable Drug-Eluting Devices Market Size by Application
4.2.1 Global Implantable Drug-Eluting Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Implantable Drug-Eluting Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Implantable Drug-Eluting Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Implantable Drug-Eluting Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Implantable Drug-Eluting Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Implantable Drug-Eluting Devices Sales Breakdown by Application (2018-2023)
5 North America Implantable Drug-Eluting Devices by Country
5.1 North America Implantable Drug-Eluting Devices Historic Market Size by Country
5.1.1 North America Implantable Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Implantable Drug-Eluting Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Implantable Drug-Eluting Devices Sales in Value by Country (2018-2023)
5.2 North America Implantable Drug-Eluting Devices Forecasted Market Size by Country
5.2.1 North America Implantable Drug-Eluting Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Implantable Drug-Eluting Devices Sales in Value by Country (2024-2029)
6 Europe Implantable Drug-Eluting Devices by Country
6.1 Europe Implantable Drug-Eluting Devices Historic Market Size by Country
6.1.1 Europe Implantable Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Implantable Drug-Eluting Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Implantable Drug-Eluting Devices Sales in Value by Country (2018-2023)
6.2 Europe Implantable Drug-Eluting Devices Forecasted Market Size by Country
6.2.1 Europe Implantable Drug-Eluting Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Implantable Drug-Eluting Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Implantable Drug-Eluting Devices by Region
7.1 Asia-Pacific Implantable Drug-Eluting Devices Historic Market Size by Region
7.1.1 Asia-Pacific Implantable Drug-Eluting Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Implantable Drug-Eluting Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Implantable Drug-Eluting Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Implantable Drug-Eluting Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Implantable Drug-Eluting Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Implantable Drug-Eluting Devices Sales in Value by Region (2024-2029)
8 Latin America Implantable Drug-Eluting Devices by Country
8.1 Latin America Implantable Drug-Eluting Devices Historic Market Size by Country
8.1.1 Latin America Implantable Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Implantable Drug-Eluting Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Implantable Drug-Eluting Devices Sales in Value by Country (2018-2023)
8.2 Latin America Implantable Drug-Eluting Devices Forecasted Market Size by Country
8.2.1 Latin America Implantable Drug-Eluting Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Implantable Drug-Eluting Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Implantable Drug-Eluting Devices by Country
9.1 Middle East and Africa Implantable Drug-Eluting Devices Historic Market Size by Country
9.1.1 Middle East and Africa Implantable Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Implantable Drug-Eluting Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Implantable Drug-Eluting Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Implantable Drug-Eluting Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Implantable Drug-Eluting Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Implantable Drug-Eluting Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
10.1.5 Pfizer Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
10.2.5 Medtronic Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Implantable Drug-Eluting Devices Products Offered
10.3.5 Merck Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Information
10.4.2 Bayer AG Introduction and Business Overview
10.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
10.4.5 Bayer AG Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Abbott
10.6.1 Abbott Company Information
10.6.2 Abbott Introduction and Business Overview
10.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
10.6.5 Abbott Recent Development
10.7 Surmodics
10.7.1 Surmodics Company Information
10.7.2 Surmodics Introduction and Business Overview
10.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
10.7.5 Surmodics Recent Development
10.8 Boston Scientific Corporation
10.8.1 Boston Scientific Corporation Company Information
10.8.2 Boston Scientific Corporation Introduction and Business Overview
10.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
10.8.5 Boston Scientific Corporation Recent Development
10.9 Titan Pharmaceuticals, Inc.
10.9.1 Titan Pharmaceuticals, Inc. Company Information
10.9.2 Titan Pharmaceuticals, Inc. Introduction and Business Overview
10.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
10.9.5 Titan Pharmaceuticals, Inc. Recent Development
10.10 BIOTRONIK
10.10.1 BIOTRONIK Company Information
10.10.2 BIOTRONIK Introduction and Business Overview
10.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
10.10.5 BIOTRONIK Recent Development
10.11 Allergan
10.11.1 Allergan Company Information
10.11.2 Allergan Introduction and Business Overview
10.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Allergan Implantable Drug-Eluting Devices Products Offered
10.11.5 Allergan Recent Development
10.12 Bausch & Lomb
10.12.1 Bausch & Lomb Company Information
10.12.2 Bausch & Lomb Introduction and Business Overview
10.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Products Offered
10.12.5 Bausch & Lomb Recent Development
10.13 REVA Medical
10.13.1 REVA Medical Company Information
10.13.2 REVA Medical Introduction and Business Overview
10.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 REVA Medical Implantable Drug-Eluting Devices Products Offered
10.13.5 REVA Medical Recent Development
10.14 MicroPort Medical
10.14.1 MicroPort Medical Company Information
10.14.2 MicroPort Medical Introduction and Business Overview
10.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 MicroPort Medical Implantable Drug-Eluting Devices Products Offered
10.14.5 MicroPort Medical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Implantable Drug-Eluting Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Implantable Drug-Eluting Devices Industrial Chain Analysis
11.4 Implantable Drug-Eluting Devices Market Dynamics
11.4.1 Implantable Drug-Eluting Devices Industry Trends
11.4.2 Implantable Drug-Eluting Devices Market Drivers
11.4.3 Implantable Drug-Eluting Devices Market Challenges
11.4.4 Implantable Drug-Eluting Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Implantable Drug-Eluting Devices Distributors
12.3 Implantable Drug-Eluting Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock